These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 32652376)
41. A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016. Smith N; Martins SS; Kim J; Rivera-Aguirre A; Fink DS; Castillo-Carniglia A; Henry SG; Mooney SJ; Marshall BDL; Davis C; Cerdá M Addiction; 2019 Feb; 114(2):248-258. PubMed ID: 30207015 [TBL] [Abstract][Full Text] [Related]
42. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program. Fink PB; Deyo RA; Hallvik SE; Hildebran C Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988 [TBL] [Abstract][Full Text] [Related]
43. Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences. Kim B J Health Econ; 2021 Jan; 75():102408. PubMed ID: 33316762 [TBL] [Abstract][Full Text] [Related]
44. Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D. Yarbrough CR Health Serv Res; 2018 Apr; 53(2):671-689. PubMed ID: 28101955 [TBL] [Abstract][Full Text] [Related]
45. Association of State-Level Opioid-Reduction Policies With Pediatric Opioid Poisoning. Toce MS; Michelson K; Hudgins J; Burns MM; Monuteaux MC; Bourgeois FT JAMA Pediatr; 2020 Oct; 174(10):961-968. PubMed ID: 32658263 [TBL] [Abstract][Full Text] [Related]
46. A crisis of opioids and the limits of prescription control: United States. Kertesz SG; Gordon AJ Addiction; 2019 Jan; 114(1):169-180. PubMed ID: 30039595 [TBL] [Abstract][Full Text] [Related]
47. Changes in Opioid Prescribing Following the Implementation of State Policies Limiting Morphine Equivalent Daily Dose in a Commercially Insured Population. Heins SE; Castillo RC Med Care; 2021 Sep; 59(9):801-807. PubMed ID: 34081679 [TBL] [Abstract][Full Text] [Related]
48. High-Risk Opioid Prescribing Trends: Prescription Drug Monitoring Program Data From 2010 to 2018. Ball SJ; Simpson K; Zhang J; Marsden J; Heidari K; Moran WP; Mauldin PD; McCauley JL J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):379-384. PubMed ID: 32956292 [TBL] [Abstract][Full Text] [Related]
49. Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing. McGinty EE; Stuart EA; Caleb Alexander G; Barry CL; Bicket MC; Rutkow L Implement Sci; 2018 Feb; 13(1):37. PubMed ID: 29482599 [TBL] [Abstract][Full Text] [Related]
50. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines. Manders L; Abd-Elsayed A Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396 [TBL] [Abstract][Full Text] [Related]
51. Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute Pain. Keshwani S; Grande I; Maguire M; Goodin A; Vouri SM; Hincapie-Castillo JM JAMA Netw Open; 2021 Jun; 4(6):e2113383. PubMed ID: 34115125 [TBL] [Abstract][Full Text] [Related]
52. Effect of pill mill laws on opioid overdose deaths in Ohio & Tennessee: A mixed-methods case study. Brighthaupt SC; Stone EM; Rutkow L; McGinty EE Prev Med; 2019 Sep; 126():105736. PubMed ID: 31152831 [TBL] [Abstract][Full Text] [Related]
53. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees. Wen H; Hockenberry JM JAMA Intern Med; 2018 May; 178(5):673-679. PubMed ID: 29610827 [TBL] [Abstract][Full Text] [Related]
54. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study. Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747 [TBL] [Abstract][Full Text] [Related]
55. Association of a State Prescribing Limits Policy with Opioid Prescribing and Long-term Use: an Interrupted Time Series Analysis. Treitler P; Samples H; Hermida R; Crystal S J Gen Intern Med; 2023 Jun; 38(8):1862-1870. PubMed ID: 36609812 [TBL] [Abstract][Full Text] [Related]
56. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect. Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965 [TBL] [Abstract][Full Text] [Related]
57. Patterns of opioid initiation at first visits for pain in United States primary care settings. Mundkur ML; Rough K; Huybrechts KF; Levin R; Gagne JJ; Desai RJ; Patorno E; Choudhry NK; Bateman BT Pharmacoepidemiol Drug Saf; 2018 May; 27(5):495-503. PubMed ID: 28971545 [TBL] [Abstract][Full Text] [Related]
59. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis. Chang HY; Lyapustina T; Rutkow L; Daubresse M; Richey M; Faul M; Stuart EA; Alexander GC Drug Alcohol Depend; 2016 Aug; 165():1-8. PubMed ID: 27264166 [TBL] [Abstract][Full Text] [Related]